Evidence map›Paper›PMID 35084360›Full record

ArticleBMJ open2021

Life-years lost by COVID-19 patients in public hospitals of Marseille (APHM-South-Eastern France): a limited death toll: a retrospective analysis.

Sylvie Arlotto, Alice Garès, Audrey Giraud-Gatineau, Jean Cristophe Lagier, Marie-Thérèse Jimeno, Patrick Peretti-Watel, Matthieu Million, Philippe Parola, Philippe Brouqui, Didier Raoult and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Sylvie ArlottoAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Alice GarèsAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Audrey Giraud-GatineauVITROME, IRD, Marseille, France.
Jean Cristophe LagierAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Marie-Thérèse JimenoService d'Information Médicale Public health Department La Timone Hospital, APHM, Marseille, France.
Patrick Peretti-WatelVITROME, IRD, Marseille, France.
Matthieu MillionAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Philippe ParolaVITROME, IRD, Marseille, France.
Philippe BrouquiAssistance Publique - Hôpitaux de Marseille, Marseille, France.ORCID 0000-0002-6125-2805
Didier RaoultAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Stephanie GentileService d'Evaluation Médicale, Assistance Publique Hopitaux de Marseille, Marseille, France stephanie.gentile@ap-hm.fr.
Aix-Marseille Université · FRAssistance Publique Hôpitaux de Marseille · FRMéditerranée Infection Foundation · FRARPE PACA · FRHôpital de la Timone · FRSanté Publique France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBetween 1 March and 15 June, France experienced the first wave of the COVID-19 pandemic, during which 29 549 deaths occurred among COVID-19 patients, 17 250 of whom died in hospital. Our hypothesis is that crude mortality rates are not sufficient to assess the impact of the epidemic on public health. The objective of this paper is to estimate the potential years of life lost (YLL) of patients who died from COVID-19.

methodWe realised a retrospective analysis of the exhaustive sample of COVID-19 PCR-positive patients who died in public hospitals of Marseille during this first wave. Data on demographic characteristics, comorbidities and care pathways were collected from medical records. The Charlson Comorbidity Index (CCI) was used to assess what would have been the probability of dying within 1 year of these patients in the absence of COVID-19 and to estimate total YLL.

resultsAmong the 1631 patients who were hospitalised for COVID-19, 178 patients died, at an average age of 80 years. According to CCI, 88.8% of the deceased patients had an 85% probability of dying within 1 year before COVID-19. Among the 11.2% who had a lower CCI probability, 18 out of 20 had at least one additional comorbidity known to be a major risk factor of mortality in COVID-19 disease. Cumulative total number of YLL was estimated to be 541 in this deceased population, that is, an average of 3 YLL.

conclusionAlthough our results should be interpreted with caution, this analysis confirms that mortality due to COVID-19 translates into a limited number of YLL due to both old age and preexisting comorbidities in the most vulnerable patients. This fact should be better considered in public health management of the pandemic both for risk communication and design of the most appropriate protective measures.

Indexed as

COVID-19Aged, 80 and overComorbidityFranceHospitals, PublicHumansPandemicsRetrospective StudiesSARS-CoV-2COVID-19epidemiologypublic health

Identifiers

PMID35084360
PMCPMC8718937
OpenAlexW4205427812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.